How many of those listed BMY drugs were actually invented or discovered internally by BMY research? What is it that BMY seems to be doing successfully?
Yervoy certainly wasn't invented at BMY, it being the principal monoclonal in the pipeline of MEDX, which BMY acquired. Has anyone seen what has happened to the remains of the MEDX pipeline? Once MEDX- wholly-owned Genmab sub has had recent success, per Van Winkle.
Apart from Eliquis[which remains to be seen;was that an acquired or internally discovered product, in any event?], the other BMY products you mention seem to have little revenue value so far.
BMY has been quite successful in acquiring other companies AND their pipelines, AMLN being perhaps[TO expires 08/07/2012 unless extended] the most recent example. Does anyone think that BMY's own internal research is worth the powder to blow it to h....?
I do not denigrate BMY inasmuch as we own a substantial number of still profitable shares. By now, however, IMO. our 20k shares of MEDX @$6.50 basis would have yielded more $/share than achieved so far with BMY.
Market Data 
Markets 
AI
